Cleveland Clinic has published guidance addressing the use of GLP-1 receptor agonist medications, a class of drugs originally developed for diabetes management that have gained attention for weight loss applications. The guidance appears intended to help patients and healthcare providers understand the appropriate use, benefits, and considerations associated with these medications. This resource may be relevant to individuals considering or currently using GLP-1 medications, as well as healthcare professionals involved in patient care decisions.
Weight & Metabolism · Jun 12, 2026 · 14 hours ago
Cleveland Clinic Releases Guidance on GLP-1 Medications
Read the full story at Cleveland Clinic →
This summary was prepared by the HealthyFreePress editorial desk; the underlying reporting belongs to the linked publisher. Nothing here is medical advice — see our Medical Disclaimer and Editorial Policy.